Načítá se...
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
BACKGROUND: Full-thickness articular cartilage injury of the knee is a major cause of disability. The aim of this study is to assess the outcome of patients treated with differentiated to chondrocytes bone marrow mesenchymal stem cells (BM-MSCs) cultured on a collagen type I/III (Chondro-Gide®) scaf...
Uloženo v:
| Vydáno v: | J Orthop Surg Res |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7539404/ https://ncbi.nlm.nih.gov/pubmed/33023626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13018-020-01852-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|